Exosomal miR-192-5p secreted by bone marrow mesenchymal stem cells inhibits hepatic stellate cell activation and targets PPP2R3A

References

• Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4):875.
   PubMed Web of Science ®Google Scholar
• Aydın MM, Akçalı KC. Liver fibrosis. Turk J Gastroenterol. 2018;29(1):14–21.
   PubMed Web of Science ®Google Scholar
• Shi Y, Yan T, Lu X, et al. Phloridzin reveals new treatment strategies for liver fibrosis. Pharmaceuticals (Basel). 2022;15(7):896.
   PubMedGoogle Scholar
• Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27–42.
   PubMed Web of Science ®Google Scholar
• Arroyo N, Villamayor L, Díaz I, et al. GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells. JCI Insight. 2021;6(23).
   PubMed Web of Science ®Google Scholar
• Huang Y, Deng X, Liang J. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis. Exp Cell Res. 2017;352(2):420–426.
   PubMed Web of Science ®Google Scholar
• Tadokoro T, Morishita A, Masaki T. Diagnosis and therapeutic management of liver fibrosis by MicroRNA. Int J Mol Sci. 2021;22(15):8139.
   PubMed Web of Science ®Google Scholar
• Beerts C, Brondeel C, Pauwelyn G, et al. Scintigraphic tracking of (99m)Technetium-labelled equine peripheral blood-derived mesenchymal stem cells after intravenous, intramuscular, and subcutaneous injection in healthy dogs. Stem Cell Res Ther. 2021;12(1):393.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang S, Zhang W, et al. Bone marrow mesenchymal stem cells facilitate diabetic wound healing through the restoration of epidermal cell autophagy via the HIF-1α/TGF-β1/SMAD pathway. Stem Cell Res Ther. 2022;13(1):314.
   PubMed Web of Science ®Google Scholar
• Fu D, Liu B, Jiang H, et al. Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-1-5p reduces proliferation and raises apoptosis of bladder cancer cells via targeting ABL2. Genomics. 2021;113(3):1338–1348.
   PubMed Web of Science ®Google Scholar
• Jin Y, Xu M, Zhu H, et al. Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis. J Cell Mol Med. 2021;25(19):9281–9294.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jiao G, Ren S, et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis in a rat model of nonunion. Stem Cell Res Ther. 2020;11(1):38.
   PubMed Web of Science ®Google Scholar
• Lou G, Chen Z, Zheng M, et al. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6):e346.
   PubMed Web of Science ®Google Scholar
• Rong X, Liu J, Yao X, et al. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway. Stem Cell Res Ther. 2019;10(1):98.
   PubMed Web of Science ®Google Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
   PubMed Web of Science ®Google Scholar
• Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: formation–Function–Future. Int J Mol Sci. 2016;17(12):2028.
   PubMed Web of Science ®Google Scholar
• Tian S, Zhou X, Zhang M, et al. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages. Stem Cell Res Ther. 2022;13(1):330.
   PubMed Web of Science ®Google Scholar
• Bae M, Kim MB, Lee JY. Astaxanthin attenuates the changes in the expression of MicroRNAs involved in the activation of hepatic stellate cells. Nutrients. 2022;14(5):962.
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhu L, Iok in I, et al. Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis. Int Immunopharmacol. 2020;78:105985.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou N, Liu Y, et al. Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells. Stem Cell Res Ther. 2021;12(1):153.
   PubMed Web of Science ®Google Scholar
• Feng Y, Li Y, Xu M, et al. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis. Stem Cell Res Ther. 2022;13(1):375.
   PubMed Web of Science ®Google Scholar
• Chen J, Yu Y, Li S, et al. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy. J Cell Mol Med. 2017;21(12):3679–3692.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhou S, Zhang Y, et al. Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3β and inhibiting the Wnt3a/β-catenin pathway. Infect Agent Cancer. 2022;17(1):17.
   PubMed Web of Science ®Google Scholar
• Poilil Surendran S, George Thomas R, Moon M-J, et al. Nanoparticles for the treatment of liver fibrosis. Int J Nanomedicine. 2017;12:6997–7006.
   PubMed Web of Science ®Google Scholar
• Dewidar B, Meyer C, Dooley S, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis—updated 2019. Cells. 2019;8(11):1419.
   PubMed Web of Science ®Google Scholar
• Chen HC, Awale S, Wu C-P, et al. Co-cultured bone marrow mesenchymal stem cells repair thioacetamide-induced hepatocyte damage. Cell Biol Int. 2020;44(12):2459–2472.
   PubMed Web of Science ®Google Scholar
• Khalil MR, El-Demerdash RS, Elminshawy HH, et al. Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. Biomed J. 2021;44(5):598–610.
   PubMed Web of Science ®Google Scholar
• Rostom DM, Attia N, Khalifa HM, et al. The therapeutic potential of extracellular vesicles versus mesenchymal stem cells in liver damaged. Tissue Eng Regen Me. 2020;17(4):537–552.
   PubMed Web of Science ®Google Scholar
• Chen Q, Liu Y, Ding X, et al. Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7. Mol Cell Biochem. 2020;465(1–2):103–114.
   PubMed Web of Science ®Google Scholar
• Yang M, Lin L, Sha C, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN. Lab Invest. 2020;100(3):342–352.
   PubMed Web of Science ®Google Scholar
• Chen L, Lu F-B, Chen D-Z, et al. Bmscs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2018;93:38–46.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRnas. Annu Rev Biochem. 2010;79:351–379.
   PubMed Web of Science ®Google Scholar
• Göder A, Emmerich C, Nikolova T, et al. HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130. Nat Commun. 2018;9(1):764.
   PubMed Web of Science ®Google Scholar
• Chen H, Xu J, Wang P, et al. “Protein phosphatase 2 regulatory subunit B” Alpha silencing inhibits tumor cell proliferation in liver cancer. Cancer Med. 2019;8(18):7741–7753.
   PubMed Web of Science ®Google Scholar
• He JJ, Shang L, Yu Q-W, et al. High expression of protein phosphatase 2 regulatory subunit B’’ alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World J Gastrointest Oncol. 2021;13(7):716–731.
   PubMed Web of Science ®Google Scholar
• Shi X, Wang J, Zhang X, et al. GREM1/PPP2R3A expression in heterogeneous fibroblasts initiates pulmonary fibrosis. Cell Biosci. 2022;12(1):123.
   PubMed Web of Science ®Google Scholar